M&A Starting to Pick Up as Valuations Come Down
October 04, 2019
Yang, Difei
Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola
A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju
Major Pharmas Becoming Increasingly Comfortable with Gene Therapy
March 22, 2019
Zhong, Yun
Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit
Big Pharma Looking to Small-Cap Biotechs for Innovation
March 15, 2019
Vandermosten, John
Gene Therapy Companies with Better Clinical Data and Benefits Likely to Do Well
October 02, 2018
Yang, Difei
Relatively Healthy Valuations for Development-Stage Companies
October 02, 2018
Nierengarten, David
Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola
Biotech and Pharma Companies Set For Milestones in 2018
March 08, 2018
Nash, Edward
Biotech Space on the Cusp of Seismic Changes
April 21, 2017
Chattopadhyay, Debjit
Gene Therapy Space Grows More Disruptive and Competitive
April 21, 2017
Nash, Edward
A Tepid Outlook on Revenue Growth for Biopharmaceutical Companies
March 10, 2017
Amusa, Gbola
Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola
